Trial intelligence / Profile preview

Exparel for Pain Control in Costal Cartilage Harvest

NCT05285566Phase 4Recruiting

Sponsor
Mayo Clinic
Start
May 2022
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine extended release liposome injection in postoperative pain, sponsored by Mayo Clinic. Started May 2022; status: recruiting.

02

Drugs

bupivacaine extended release liposome injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05285566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05285566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call